Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: Implications for targeted EZH2 inhibitor therapy?-Reference-Cited by-同舟云学术

Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: Implications for targeted EZH2 inhibitor therapy?

Published:2015-02-05 Issue:18 Volume:6 Page:16712-16724
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dubois Sydney¹,Mareschal Sylvain¹,Picquenot Jean-Michel¹²,Viailly Pierre-Julien¹,Bohers Elodie¹,Cornic Marie²,Bertrand Philippe¹,Veresezan Elena Liana¹²,Ruminy Philippe¹,Maingonnat Catherine¹,Marchand Vinciane¹,Lanic Hélène¹³,Penther Dominique¹,Bastard Christian¹,Tilly Hervé¹³,Jardin Fabrice¹³

Affiliation:

1. INSERM U918, Centre Henri Becquerel, Université de Rouen, IRIB, Rouen, France

2. Department of Pathology, Centre Henri Becquerel, Rouen, France

3. Department of Clinical Hematology, Centre Henri Becquerel, Rouen, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group;Cancer Genetics;2022-11

2. ctDNA Is Useful to Detect Mutations at Codon 641 of Exon 16 of EZH2, a Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma;Cancers;2022-09-24

3. Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes;Modern Pathology;2022-09

4. Next-Generation Sequencing Highlights of Diffuse Large B-cell Lymphoma in a Tertiary Care Hospital in North India;Cureus;2022-08-21

5. H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas;Virchows Archiv;2022-06-04